Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
PFAS remediation and capital program drive part of AWA's near‑term plans; RWA patent and technology spending noted
Summary
Company witnesses told the PURA hearing that substantial capital investment and technology upgrades—including PFAS treatment projects—are planned for Aquarion’s system; witnesses also said RWA has a pending patent for an innovative PFAS treatment and that separate technology spending of roughly $37–$39 million through 2029 was in the exhibits.
Company witnesses and interveners at the PURA hearing discussed PFAS remediation and the capital program that the acquiring authority (AWA) intends to implement after acquisition.
Lede: Applicants said Aquarion will continue its capital program and that AWA plans substantial investments to address PFAS and other infrastructure needs; company witnesses identified projected technology spending of roughly $37–39 million through 2029 and said an RWA‑developed PFAS treatment patent is pending and under consideration.
Nut Graf: Both applicant testimony and interrogatory exhibits list PFAS and other treatment projects as necessary, regardless of ownership. Company witnesses said those projects are part of the 10‑year capital plan that drives the early rate…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
